Cost-Effectiveness Analysis of4Therapeutic Schemes in the Treatment of Type 2 Diabetes
- VernacularTitle:4种用药方案治疗2型糖尿病的成本-效果分析
- Author:
Ling CHEN
;
Wanting ZHANG
- Publication Type:Journal Article
- Keywords:
Type2diabetes;
Antidiabetic drugs;
Cost-effectiveness analysis
- From:
China Pharmacy
2001;0(10):-
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To discuss the cost-effectiveness of4therapeutic schemes in the treatment of Type2diabetes.METHODS:Cost-effectiveness analyses were made on4therapeutic schemes by using pharmacoeconomical principle,which were:metformin+clipizde(Scheme A),metformin+pioglitazone(Scheme B),metformin+repaglinide(Scheme C),and met-formin+novolin30R(Scheme D).RESULTS:There was no significant difference in the total effective rate among4schemes.The cost-effectiveness ratios in Scheme A,B,C and D were2.21,3.21,2.63,and6.54,respectively.The cost-effectiveness ratios increments in Scheme B,C,and D were64.82,—6.41,and51.25as against Scheme A.CONCLUSION:Among the4schemes,Scheme A is the preferable choice.
